Management Difficulties in a Patient with EGFR-mutation Positive Lung Adenocarcinoma and Cerebral Metastases

Arch Bronconeumol. 2017 Jan;53(1):37-38. doi: 10.1016/j.arbres.2016.06.006. Epub 2016 Oct 3.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / diagnostic imaging
  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary*
  • Adenocarcinoma / surgery
  • Antineoplastic Agents / therapeutic use
  • Brain Neoplasms / diagnostic imaging
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / secondary*
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Drug Resistance, Neoplasm
  • Erlotinib Hydrochloride / therapeutic use
  • Genes, erbB-1*
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / surgery
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography
  • Protein Kinase Inhibitors / therapeutic use
  • Remission Induction
  • Salvage Therapy*
  • Solitary Pulmonary Nodule / diagnosis
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Erlotinib Hydrochloride